Jubilant Life Sciences Q1 PAT down 52 pc at Rs 88 crore

Sep 04, 2020

Noida (Uttar Pradesh) [India], September 4 : Jubilant Life Sciences on Friday reported 52 per cent fall in its profit after tax of Rs...

Jubilant Life Sciences surges 5 pc after signing deal with Gilead for production of Remdesivir

May 13, 2020

Mumbai (Maharashtra) [India], May 13 : The share price of Jubilant Life Sciences surged 5 per cent hitting upper circuit of Rs 429.95 per...

COVID-19: Pharma giants seek DCGI's approval to manufacture, sell Remdesivir drug

Jun 04, 2020

New Delhi [India], June 4 : Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached the country's top drug regulator--Drug Controller General of...

Jubilant launches Remdesivir in India for treatment of COVID-19

Aug 04, 2020

Noida (Uttar Pradesh) [India], Aug 4 : Jubilant Life Sciences has launched Remdesivir for injection under the brand name JUBI-R in Indian market at...

Infosys to acquire life sciences consulting firm BASE life science

Jul 13, 2022

Bengaluru (Karnataka) [India], July 13 : Infosys said on Wednesday it has signed a definitive agreement to acquire BASE life science, a leading technology...

Goldman Sachs invests in Aragen Life Sciences

May 19, 2021

Hyderabad (Telangana) [India], May 19 (ANI/BusinessWire India): Aragen Life Sciences ("Aragen"), formerly known as GVK Biosciences and a leading contract research organization (CRO),...